{
    "id": 28085,
    "cites": 45,
    "cited_by": 0,
    "reference": [
        "Ahituv, Avner, V. Joseph Holz, and Tomas Philipson. (1996) \u00c3\u00a2\u00c2\u0080\u00c2\u009cThe Responsiveness of the Demand for Condoms to the Local Prevalence of AIDS,\u00c3\u00a2\u00c2\u0080\u00c2\u009d Journal of Human Resources 31(4): 869\u00c3\u00a2\u00c2\u0080\u00c2\u0093897.",
        "Althouse, Benjamin M., Theodore C. Bergstrom, and Carl T. Bergstrom. (2010) \u00c3\u00a2\u00c2\u0080\u00c2\u009cA Public Choice Framework for Controlling Transmissible and Evolving Diseases,\u00c3\u00a2\u00c2\u0080\u00c2\u009d Proceedings of the National Academy of Sciences 107(1): 1696.",
        "Anderson, Roy and Robert May. (1991) Infectious Diseases of Humans. Oxford: Oxford University Press.",
        "Bailey, Norman. (1975) The Mathematical Theory of Infectious Diseases and Its Application. London: Griffen.",
        "Bailey, Robert C., Stephen Moses, Corette B. Parker, Kawango Agot, Kian Maclean, John N. Krieger, Carolyn F. M. Williams, Richard T. Campbell, and Jeckoniah O. Ndinya-Achola. (2007) \u00c3\u00a2\u00c2\u0080\u00c2\u009cMale Circumcision for HIV Prevention in Young Men in Kisumu, Kenya: A Randomised Controlled Trial,\u00c3\u00a2\u00c2\u0080\u00c2\u009d Lancet 369: 643\u00c3\u00a2\u00c2\u0080\u00c2\u0093656.",
        "Banerjee, Abhijit, Esther Duflo, Rachel Glennerster, and Dhruva Kothari (2010) \u00c3\u00a2\u00c2\u0080\u00c2\u009cImproving Immunization Coverage in Rural India: A Clustered Randomized Controlled Evaluation of Immunization Campaigns with and without Incentives,\u00c3\u00a2\u00c2\u0080\u00c2\u009d British Medical Journal 340.",
        "Bauch, Chris T., and David J. D. Earn. (2004) \u00c3\u00a2\u00c2\u0080\u00c2\u009cVaccination and the Theory of Games,\u00c3\u00a2\u00c2\u0080\u00c2\u009d Proceedings of the National Academy of Sciences 101(36): 13391-13394 Berndt, Ernst, Rachel Glennerster, Michael Kremer, Jean Lee, Ruth Levine, Georg Weisacker, and Heidi Williams. (2007) \u00c3\u00a2\u00c2\u0080\u00c2\u009cAdvance Market Commitments for Vaccines Against Neglected Diseases: Estimating Costs and Effectiveness,\u00c3\u00a2\u00c2\u0080\u00c2\u009d Health Economics 16: 491\u00c3\u00a2\u00c2\u0080\u00c2\u0093511.",
        "Bethune, Zachary and Anton Korinek (2020) \u00c3\u00a2\u00c2\u0080\u00c2\u009cCovid-19 Infection Externalities: Trading Off Lives vs. Livelihoods,\u00c3\u00a2\u00c2\u0080\u00c2\u009d National Bureau of Economic Research Working Paper. (No. w27009).",
        "Boulier, Bryan, Tejwant Datta, and Robert Goldfarb. (2007) \u00c3\u00a2\u00c2\u0080\u00c2\u009cVaccination Externalities,\u00c3\u00a2\u00c2\u0080\u00c2\u009d The B.E. Journal of Economic Analysis & Policy 7: www.bepress.com/bejeap/vol7/iss1/art23.",
        "Brennan, Michael J. (2009) \u00c3\u00a2\u00c2\u0080\u00c2\u009cThe US Food and Drug Administration Provides a Pathway for Licensing Vaccines for Global Diseases,\u00c3\u00a2\u00c2\u0080\u00c2\u009d PLoS Medicine 6(7): e1000095.",
        "Brito, Dagobert L., Eytan Sheshinski, and Michael D. Intrilligator. (1991) \u00c3\u00a2\u00c2\u0080\u00c2\u009cExternalities and Compulsory Vaccination,\u00c3\u00a2\u00c2\u0080\u00c2\u009d Journal of Public Economics 45: 69\u00c3\u00a2\u00c2\u0080\u00c2\u009390.",
        "Chowell, Gerardo, Paul W. Fenimore, Melissa A. Castillo-Garsow, and Carlos Castillo-Chavez. (2003) \u00c3\u00a2\u00c2\u0080\u00c2\u009cSARS Outbreaks in Ontario, Hong Kong and Singapore: The Role of Diagnosis and Isolation As a Control Mechanism,\u00c3\u00a2\u00c2\u0080\u00c2\u009d Journal of Theoretical Biology 224: 1\u00c3\u00a2\u00c2\u0080\u00c2\u00938.",
        "Cook, Joseph, Marc Jeuland, Brian Maskery, Donald Lauria, Dipika Sur, John Clemens, and Dale Whittington. (2009) \u00c3\u00a2\u00c2\u0080\u00c2\u009cUsing Private Demand Studies to Calculate Socially Optimal Caccine Subsidies in Developing Countries,\u00c3\u00a2\u00c2\u0080\u00c2\u009d Journal of Policy Analysis and Management 28 (1): 6\u00c3\u00a2\u00c2\u0080\u00c2\u0093 28.",
        "Diekmann, O. , J. A. P. Heesterbeek, and J. A. J. Metz. (1990) \u00c3\u00a2\u00c2\u0080\u00c2\u009cOn the Definition and the Computation of the Basic Reproduction Ratio R0 in Models for Infections Diseases in Heterogeneous Populations,\u00c3\u00a2\u00c2\u0080\u00c2\u009d Journal of Mathematical Biology 28: 365\u00c3\u00a2\u00c2\u0080\u00c2\u0093382. Enayati, Shakiba and Osman Y.",
        "\u00c3\u00a2\u00c2\u0080\u00c2\u0099Ozaltin. (2020) \u00c3\u00a2\u00c2\u0080\u00c2\u009cOptimal Influenza Vaccine Distribution with Equity,\u00c3\u00a2\u00c2\u0080\u00c2\u009d European Journal of Operational Research 283: 714\u00c3\u00a2\u00c2\u0080\u00c2\u0093725.",
        "Francis, Peter J. (1997) \u00c3\u00a2\u00c2\u0080\u00c2\u009cDynamic Epidemiology and the Market for Vaccinations,\u00c3\u00a2\u00c2\u0080\u00c2\u009d Journal of Public Economics 63: 383\u00c3\u00a2\u00c2\u0080\u00c2\u0093406.",
        "Funk, Sebastian, Marcel Salath\u00c3\u0083\u00c2\u00a9, and Vincent A. A. Jansen. (2010) \u00c3\u00a2\u00c2\u0080\u00c2\u009cModelling the Influence of Human Behaviour on the Spread of Infectious Diseases: A Review,\u00c3\u00a2\u00c2\u0080\u00c2\u009d Journal of The Royal Society Interface 7 (50): 1247\u00c3\u00a2\u00c2\u0080\u00c2\u009356.",
        "Galeotti, Andrea, and Brian W. Rogers. (2013) \u00c3\u00a2\u00c2\u0080\u00c2\u009cStrategic Immunization and Group Structure,\u00c3\u00a2\u00c2\u0080\u00c2\u009d American Economic Journal: Microeconomics 5(2): 1\u00c3\u00a2\u00c2\u0080\u00c2\u009332.",
        "Geoffard, Pierre-Yves and Tomas Philipson. (1997) \u00c3\u00a2\u00c2\u0080\u00c2\u009cDisease Eradication: Public vs. Private Vaccination,\u00c3\u00a2\u00c2\u0080\u00c2\u009d American Economic Review 87: 222\u00c3\u00a2\u00c2\u0080\u00c2\u0093230.",
        "Gersovitz, Mark (2003) \u00c3\u00a2\u00c2\u0080\u00c2\u009cBirths, Recoveries, Vaccinations, and Externalities,\u00c3\u00a2\u00c2\u0080\u00c2\u009d in R. Arnott (ed.) Economics for an Imperfect World: Essays in Honor of Joseph E. Stiglitz, pp. 469\u00c3\u00a2\u00c2\u0080\u00c2\u0093483.",
        "Gersovitz, Mark and Jeffrey S. Hammer. (2005) \u00c3\u00a2\u00c2\u0080\u00c2\u009cTax/Subsidy Policy Toward Vector-Borne Infectious Diseases,\u00c3\u00a2\u00c2\u0080\u00c2\u009d Journal of Public Economics 89: 647\u00c3\u00a2\u00c2\u0080\u00c2\u0093674.",
        "Hoerger, Thomas J., Sarah Schillie, John S. Wittenborn, Christina L. Bradley, Fangjun Zhou, Kathy Byrd, and Trudy V. Murphy. (2013) \u00c3\u00a2\u00c2\u0080\u00c2\u009cCost Effectiveness of Hepatitis B Vaccination in Adults with Diagnosed Diabetes,\u00c3\u00a2\u00c2\u0080\u00c2\u009d Diabetes Care 36: 63\u00c3\u00a2\u00c2\u0080\u00c2\u009369.",
        "Keeling, Matt J. and J. V. Ross. (2015) \u00c3\u00a2\u00c2\u0080\u00c2\u009cOptimal Prophylactic Vaccination in Segregated Populations: When Can We Improve on the Equalising Strategy?\u00c3\u00a2\u00c2\u0080\u00c2\u009d Epidemics 11: 7\u00c3\u00a2\u00c2\u0080\u00c2\u009313.",
        "Keeling, Matt J. and Andrew Shattock. (2012) \u00c3\u00a2\u00c2\u0080\u00c2\u009cOptimal but Inequitable Prophylactic Distribution of Vaccine,\u00c3\u00a2\u00c2\u0080\u00c2\u009d Epidemic 4: 78\u00c3\u00a2\u00c2\u0080\u00c2\u009385.",
        "Kennedy, Caitlin E., Ping T. Yeh, Kaitlyn Atkins, Virginia A. Fonner, Michael D. Sweat, Kevin R. O\u00c3\u00a2\u00c2\u0080\u00c2\u0099Reilly, George W. Rutherford, Rachel Baggaley, and Jluia Samuelson. (2020) \u00c3\u00a2\u00c2\u0080\u00c2\u009cEconomic Compensation Interventions to Increase Uptake of Voluntary Medical Male Circumcision for HIV Prevention: A Systematic Review and Meta-Analysis,\u00c3\u00a2\u00c2\u0080\u00c2\u009d PLoS ONE 15(1): e0227623.",
        "Kermack, William O. and A. G. McKendrick. (1927) \u00c3\u00a2\u00c2\u0080\u00c2\u009cA Contribution to the Mathematical Theory of Epidemics,\u00c3\u00a2\u00c2\u0080\u00c2\u009d Proceedings of the Royal Society A (Mathematical, Physical and Engineering Sciences) 115: 700\u00c3\u00a2\u00c2\u0080\u00c2\u0093721.",
        "Kissler, Stephen M., Christine Tedijanto, Edward Goldstein, Yonatan H. Grad, and Marc Lipsitch. (2020) \u00c3\u00a2\u00c2\u0080\u00c2\u009cProjecting the Transmission Dynamics of SARS-CoV-2 Through the Postpandemic Period\" Science 368(6493): 860\u00c3\u00a2\u00c2\u0080\u00c2\u0093868.",
        "Kremer, Michael. (1996) \u00c3\u00a2\u00c2\u0080\u00c2\u009cIntegrating Behavioral Choice into Epidemiological Models of AIDS,\u00c3\u00a2\u00c2\u0080\u00c2\u009d Quarterly Journal of Economics 111(2): 549\u00c3\u00a2\u00c2\u0080\u00c2\u0093573.",
        "Kremer, Michael and Christopher M. Snyder. (2015) \u00c3\u00a2\u00c2\u0080\u00c2\u009cPreventives vs. Treatments,\u00c3\u00a2\u00c2\u0080\u00c2\u009d Quarterly Journal of Economics130(3): 1167\u00c3\u00a2\u00c2\u0080\u00c2\u00931239 Kremer, Michael and Christopher M. Snyder. (2018) \u00c3\u00a2\u00c2\u0080\u00c2\u009cPreventives versus Treatments Redux: Tighter bounds on Distortions in Innovation Incentives with an Application to the Global Demand for HIV Pharmaceuticals,\u00c3\u00a2\u00c2\u0080\u00c2\u009d Review of Industrial Organization 53 (1): 235\u00c3\u00a2\u00c2\u0080\u00c2\u0093273 Manfredi, Piero, and Alberto D\u00c3\u00a2\u00c2\u0080\u00c2\u0099Onofrio (ed.) (2013) Modeling the Interplay Between Human Behavior and the Spread of Infectious Diseases. New York: Springer-Verlag.",
        "Manski, Charles F. (2017) \u00c3\u00a2\u00c2\u0080\u00c2\u009cMandating Vaccination with Unknown Indirect Effects,\u00c3\u00a2\u00c2\u0080\u00c2\u009d Journal of Public Economic Theory 19: 603\u00c3\u00a2\u00c2\u0080\u00c2\u0093619.",
        "Marseille Elliott, Bruce Larson, Dhruv S. Kazi, James G. Kahn, and Sydney Rosen. (2015) \u00c3\u00a2\u00c2\u0080\u00c2\u009cThresholds for the Cost-Effectiveness of Interventions: Alternative Approaches,\u00c3\u00a2\u00c2\u0080\u00c2\u009d Bulletin of the World Health Organization 93: 118\u00c3\u00a2\u00c2\u0080\u00c2\u0094124.",
        "Martcheva, Maia. (2015) An Introduction to Mathematical Epidemiology. New York: Springer.",
        "May, Robert. (2000) \u00c3\u00a2\u00c2\u0080\u00c2\u009cSimple Rules with Complex Dynamics,\u00c3\u00a2\u00c2\u0080\u00c2\u009d Science 287(5453): 601\u00c3\u00a2\u00c2\u0080\u00c2\u0093602.",
        "Mechoulan, St\u00c3\u0083\u00c2\u00a9phane. (2007) \u00c3\u00a2\u00c2\u0080\u00c2\u009cMarket Structure and Communicable Diseases,\u00c3\u00a2\u00c2\u0080\u00c2\u009d Canadian Journal of Economics 40: 468\u00c3\u00a2\u00c2\u0080\u00c2\u0093492.",
        "Nguyen, Chantal and Jean M. Carlson. (2016) \u00c3\u00a2\u00c2\u0080\u00c2\u0098Optimizing Real-Time Vaccine Allocation in a Stochastic SIR Model,\u00c3\u00a2\u00c2\u0080\u00c2\u009d PLoS One 11(4): e0152950.",
        "Philipson, Tomas. (2000) \u00c3\u00a2\u00c2\u0080\u00c2\u009cEconomic Epidemiology and Infectious Disease,\u00c3\u00a2\u00c2\u0080\u00c2\u009d in J. Newhouse and T. Culyer (ed.) Handbook of Health Economics, Volume IB: 443\u00c3\u00a2\u00c2\u0080\u00c2\u0093465.",
        "Tasslimi, Azadeh, Mari M. Nakamura, Orin Levine, Maria D. Knoll, Louise B. Russell, and Anushua Sinha. (2011) \u00c3\u00a2\u00c2\u0080\u00c2\u009cCost Effectiveness of Child Pneumococcal Conjugate Vaccination in GAVI-Eligible Countries,\u00c3\u00a2\u00c2\u0080\u00c2\u009d International Health 3: 259\u00c3\u00a2\u00c2\u0080\u00c2\u0093269.",
        "Thomas, Patricia. (2002) \u00c3\u00a2\u00c2\u0080\u00c2\u009cThe Economics of Vaccines,\u00c3\u00a2\u00c2\u0080\u00c2\u009d Harvard Medical International (HMI) World. September/October.",
        "Ubel, Peter A., Richard A. Hirth, and Michael E. Chernew. (2003) \u00c3\u00a2\u00c2\u0080\u00c2\u009cWhat is the Price of Life and Why Doesn\u00c3\u00a2\u00c2\u0080\u00c2\u0099t It Increase at the Rate of Inflation?\u00c3\u00a2\u00c2\u0080\u00c2\u009d Archives of Internal Medicine 163: 1637\u00c3\u00a2\u00c2\u0080\u00c2\u00931641.",
        "U.K. Government Office for Science. (2020) \u00c3\u00a2\u00c2\u0080\u00c2\u009cThe R Number and Growth Rate in the UK.\u00c3\u00a2\u00c2\u0080\u00c2\u009d [Internet.",
        "U.K. Office for National Statistics. (2020) \u00c3\u00a2\u00c2\u0080\u00c2\u009cCoronavirus (COVID-19) Infection Survey Pilot: England, Wales and Northern Ireland, 25 September 2020.\u00c3\u00a2\u00c2\u0080\u00c2\u009d [Internet.] Downloaded September 28, 2020 from https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/ conditionsanddiseases/bulletins/coronaviruscovid19infectionsurveypilot/englandwalesandno rthernireland25september2020#number-of-people-in-england-who-had-covid-19.",
        "UNAIDS/WHO/SACEMA Expert Group on Modelling the Impact and Cost of Male Circumcision for HIV Prevention. (2009) \u00c3\u00a2\u00c2\u0080\u00c2\u009cMale Circumcision for HIV Prevention in High HIV Prevalence Settings: What Can Mathematical Modelling Contribute to Informed Decision Making ?\u00c3\u00a2\u00c2\u0080\u00c2\u009d PLoS Medicine 6(9): e1000109.",
        "U.S. Centers for Disease Control and Prevention. (2020a) \u00c3\u00a2\u00c2\u0080\u00c2\u009cCDC Vaccine Price List.\u00c3\u00a2\u00c2\u0080\u00c2\u009d [Internet.] Downloaded October 8, 2020 from https://www.cdc.gov/vaccines/programs/vfc/awardees/v accine-management/price-list/index.html.",
        "U.S. Centers for Disease Control and Prevention. (2020b) \u00c3\u00a2\u00c2\u0080\u00c2\u009cVaccines and Preventable Diseases: Vaccines by Disease.\u00c3\u00a2\u00c2\u0080\u00c2\u009d [Internet.] Vaccine efficacies downloaded August 28, 2020 from https: //www.cdc.gov/vaccines/pubs/pinkbook/hepb.html for hepatitis B, from https://www. cdc.gov/vaccines/vpd/mmr/public/index.html for measles, from https://www.cdc.gov/ vaccines/vpd/dtap-tdap-td/hcp/about-vaccine.html for pertussis and tetanus, from https: //www.cdc.gov/vaccines/vpd/polio/index.html for polio, and from from https://www.cdc.gov/ vaccines/vpd/shingles/index.html for shingles.",
        "U.S. General Accounting Office. (2002) \u00c3\u00a2\u00c2\u0080\u00c2\u009cChildhood Vaccines: Ensuring an Adequate Supply Poses Continuing Challenges,\u00c3\u00a2\u00c2\u0080\u00c2\u009d Report no. GAO-02-987."
    ]
}